文献速递脑血管病

主动脉弓斑块与他汀时代卒中及心血管事件的长期风险

Aortic Arch Plaques and the Long-Term Risk of Stroke and Cardiovascular Events in the Statin Era.
PubMed 文献 · Stroke · 2023-12-08

CABL研究中934名无卒中老年人接受经胸超声评估主动脉弓斑块,平均随访11.3±3.6年。大斑块与复合心血管事件独立相关(校正HR 2.19,95%CI 1.40-3.43),但与卒中单独无显著关联(校正HR 1.09,95%CI 0.50-2.38)。大斑块与事件的关联仅在接受他汀者中显著(校正HR 2.57,95%CI 1.52-4.37)。

要点

  • 大主动脉弓斑块与复合心血管事件独立相关,校正HR 2.19(95%CI 1.40-3.43)。
  • 大斑块与缺血性卒中单独无显著关联,校正HR 1.09(95%CI 0.50-2.38)。
  • 大斑块与事件的关联仅在接受他汀者中显著,接受他汀者风险谱也更差。

核心结论

  • 在无卒中史的老年人中,主动脉弓斑块可能是心血管风险的标志物而非直接栓塞性卒中来源。
  • 对主动脉弓斑块个体,超越胆固醇水平的更广泛心血管危险因素控制用于一级预防的疗效可能需进一步研究。

研究设计与样本

  • CABL研究(心血管异常与脑病变)纳入934名无卒中参与者,年龄72±9岁,男性37%。
  • 经胸骨上窝超声心动图评估主动脉弓斑块,厚度≥4 mm定义为大斑块。
  • 主要结局为缺血性卒中,次要结局为复合心血管事件(缺血性卒中、心肌梗死和心血管死亡)。
  • 以无斑块为参照,并按是否接受他汀治疗分析斑块相关结局风险。

主要发现

  • 645名(69.1%)存在主动脉弓斑块,其中114名(12.2%)为大斑块。
  • 平均随访11.3±3.6年,236名(25.3%)发生心血管事件,包括76例缺血性卒中、27例心肌梗死和133例心血管死亡。
  • 大斑块与复合事件独立相关,校正HR 2.19(95%CI 1.40-3.43);与卒中单独无显著关联,校正HR 1.09(95%CI 0.50-2.38)。
  • 大斑块与心血管事件的关联在接受他汀者中显著(校正HR 2.57,95%CI 1.52-4.37),在未接受他汀者中不显著。
  • 接受他汀治疗者风险谱更差:体重指数更高,高血压、糖尿病和冠状动脉疾病频率更高。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为,主动脉弓斑块可能是无卒中史老年人心血管风险的标志物而非直接栓塞性卒中来源。
  • 作者提出,对主动脉弓斑块个体超越胆固醇水平的更广泛心血管危险因素控制用于一级预防的疗效可能需进一步研究。

局限性

  • 接受他汀治疗者风险谱更差:体重指数更高,高血压、糖尿病和冠状动脉疾病频率更高。
  • 对主动脉弓斑块个体更广泛心血管危险因素控制用于一级预防的疗效可能需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aortic arch plaques are associated with an increased risk of ischemic stroke in patients with cryptogenic stroke or prior embolic events. However, this relationship is unclear in the community. We investigated (1) the long-term risk of stroke and cardiovascular events associated with arch plaques and (2) whether statin therapy prescribed for any indication modified the association. METHODS: A total of 934 stroke-free participants (72±9 years; 37% men) from the CABL study (Cardiovascular Abnormalities and Brain Lesion) were evaluated. Arch plaques were assessed by suprasternal transthoracic echocardiography; plaques ≥4 mm in thickness were classified as large plaques. The primary outcome was ischemic stroke; the secondary outcome was combined cardiovascular events (ischemic stroke, myocardial infarction, and cardiovascular death). The plaque-related risk of outcomes was also analyzed according to the presence of statin treatment. No plaque was used as a reference. RESULTS: Aortic arch plaques were present in 645 participants (69.1%), with large plaques in 114 (12.2%). During a mean follow-up of 11.3±3.6 years, 236 (25.3%) cardiovascular events occurred (76 ischemic strokes, 27 myocardial infarctions, and 133 cardiovascular deaths). Large arch plaques were independently associated with combined events (adjusted hazard ratio, 2.19 [95% CI, 1.40-3.43]) but not stroke alone (adjusted hazard ratio, 1.09 [95% CI, 0.50-2.38]). The association between large plaques and cardiovascular events was significant in participants receiving statins (adjusted hazard ratio, 2.57 [95% CI, 1.52-4.37]) but not in others; however, participants on statin treatment also had a worse risk profile (higher body mass index, greater frequencies of hypertension, diabetes, and coronary artery disease). CONCLUSIONS: Aortic arch plaques may be a marker of cardiovascular risk rather than a direct embolic stroke source in older adults without prior stroke. The efficacy of broader cardiovascular risk factors control, beyond cholesterol levels alone, for primary prevention of cardiovascular events in individuals with aortic arch plaques may require further investigation.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Yoshida Y, Jin Z, Mannina C, et al. Aortic Arch Plaques and the Long-Term Risk of Stroke and Cardiovascular Events in the Statin Era. Stroke. 2023. PMID: 38063018. doi:10.1161/STROKEAHA.123.044546

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。